Published in Drug Week, December 3rd, 2004
Genetic Engineering News presented this award during the September BIOPHEX 2004 conference held in San Francisco, California.
Matsunaga is being recognized for his discovery and research on the world's first injectable microbubble (MRX-115), which ImaRx sold to DuPont.
Bristol-Myers Squibb Medical Imaging, Inc., subsequently acquired DuPont and named the microbubble Definity, which is now a top-selling diagnostic contrast agent.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.